Teleflex Incorporated (TFX)

NYSE: TFX · IEX Real-Time Price · USD
221.79
+1.52 (0.69%)
Jul 19, 2024, 4:00 PM EDT - Market closed
0.69%
Market Cap 10.45B
Revenue (ttm) 3.00B
Net Income (ttm) 294.87M
Shares Out 47.10M
EPS (ttm) 6.22
PE Ratio 35.66
Forward PE 15.59
Dividend $1.36 (0.61%)
Ex-Dividend Date May 14, 2024
Volume 233,746
Open 222.25
Previous Close 220.27
Day's Range 217.17 - 224.95
52-Week Range 177.63 - 262.97
Beta 1.13
Analysts Buy
Price Target 257.44 (+16.07%)
Earnings Date Aug 1, 2024

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional prod... [Read more]

Sector Healthcare
Founded 1943
Employees 14,500
Stock Exchange NYSE
Ticker Symbol TFX
Full Company Profile

Financial Performance

In 2023, Teleflex's revenue was $2.97 billion, an increase of 6.57% compared to the previous year's $2.79 billion. Earnings were $356.33 million, a decrease of -1.88%.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is $257.44, which is an increase of 16.07% from the latest price.

Price Target
$257.44
(16.07% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Teleflex Announces Second Quarter 2024 Earnings Conference Call Information

WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m...

3 days ago - GlobeNewsWire

This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst

Teleflex Inc TFX benefited in the first quarter from the surge in the interventional segment and other tailwinds.

20 days ago - Benzinga

US FDA classifies recall of Teleflex's inflatable devices as 'most serious'

The U.S. Food and Drug Administration classified a recall of Teleflex's inflatable devices that increase blood supply to the heart muscle as "most serious".

5 weeks ago - Reuters

Teleflex Publishes 2023 Global Impact Report

Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program

2 months ago - GlobeNewsWire

Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray

The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration

2 months ago - GlobeNewsWire

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 America...

2 months ago - GlobeNewsWire

Teleflex Announces Quarterly Dividend

WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of ...

2 months ago - GlobeNewsWire

Teleflex beats quarterly profit estimates on healthy demand for medical devices

Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices.

2 months ago - Reuters

Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook

WAYNE, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024.

2 months ago - GlobeNewsWire

Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting

WAYNE, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of multiple clinical studies at the 2024 Ameri...

2 months ago - GlobeNewsWire

Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire

Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire intended to introduce and position catheters and other interventional devices w...

2 months ago - GlobeNewsWire

Teleflex to Present at the BofA Securities 2024 Health Care Conference

WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at t...

2 months ago - GlobeNewsWire

Teleflex Announces First Quarter 2024 Earnings Conference Call Information

WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m...

3 months ago - GlobeNewsWire

Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tis...

3 months ago - GlobeNewsWire

Teleflex's Climate Targets Validated by the Science Based Targets Initiative

Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050. Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050.

4 months ago - GlobeNewsWire

Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors' and officers' possible violati...

4 months ago - Business Wire

Teleflex beats quarterly profit estimates on strong demand for medical devices

Teleflex reported fourth-quarter profit above Wall Street estimates on Thursday, on the back of strong demand for its medical devices and surgical equipment.

5 months ago - Reuters

Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results

WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2023. Fourth quarter financi...

5 months ago - GlobeNewsWire

Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference

WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors...

5 months ago - GlobeNewsWire

Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information

WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m...

5 months ago - GlobeNewsWire

Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement

A New Choice for Bariatric Surgeons:  Titan SGS ™ Standard Staple Line Reinforcement  with GORE ® SEAMGUARD ® Bioabsorbable Staple Line Reinforcement

6 months ago - GlobeNewsWire

Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference

WAYNE, Pa., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 42nd Annual J.P. Morgan Healthcare Conference at ...

7 months ago - GlobeNewsWire

Teleflex Awarded Peripheral Access Agreement with Premier, Inc.

WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agre...

8 months ago - GlobeNewsWire

Should You Pick Teleflex Stock After 20% Gains This Month?

Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.

8 months ago - Forbes

Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry

Registry Intends to Examine Contemporary On-Label Use of the MANTA™ Vascular Closure Device Including Appropriate Patient Selection and Proper Vascular Access Registry Intends to Examine Contemporary ...

8 months ago - GlobeNewsWire